Illumina, Inc. - Common Stock — Liquidità (NASDAQ:ILMN)

Financials

Flusso di cassa derivante dalle attività operative 1.08 B545 M392 M478 M837 M1.08 B 1.13 B Flussi di cassa derivanti dalle attività di investimento -554 M-1.07 B-591 M-231 M-178 M-55 M -358 M Liquidità derivante dalle attività di finanziamento -766 M-51 M1 B-1.21 B-570 M-744 M -800 M Liquidità libera 1.08 B545 M392 M478 M837 M931 M 974 M

Illumina, Inc. - Common Stock

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries. Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.

ILMN

Financials

Illumina, Inc. - Common Stock

Notizie

Is QGEN Stock a Hold After the 2026 Outlook Cut and Q1 Miss?

Dow Jones Futures: Stock Market Hits Highs On U.S.-Iran Deal; Dell Surges On Earnings

Il titolo di Illumina raggiunge il massimo di 52 settimane a $164,11

QIAGEN Business Breakdown and Growth Drivers for 2026

Here's Why Illumina (ILMN) is a Strong Momentum Stock

Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy?

Is This the Right Time to Retain ILMN Stock in Your Portfolio?

Il direttore di Illumina Keith Meister vende azioni per 47,9 milioni di dollari

RBC Capital avvia copertura su Illumina con rating outperform

What CEOs from Tesla, Nvidia and over a dozen other companies hope to gain by joining Trump in China

Elon Musk To Join Trump On China State Visit. Tesla Stock Sinks.

Musk e Fink nella delegazione USA in Cina con Trump